Matthew D. Galsky, Begoña P. Valderrama, Marco Maruzzo, Albert Font Pous, Tudor-Eliade Ciuleanu, Jonathan Alexander Chatzkel, Takuya Koie, Christopher J. Hoimes, Javier Puente, Yousef Zakharia, Eli Rosenbaum, Katharina Boehm, Yohann Loriot, Jens Bedke, Heidi Wirtz, Mike Mihm, Qinlei Huang, Josh Rogiers, Blanca Homet Moreno, Alfonso Gomez De Liaño Lista. "Neoadjuvant and adjuvant enfortumab vedotin (EV) plus pembrolizumab (pembro) for participants with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin: Randomized, open-label, phase 3 KEYNOTE-B15 study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.lba630